Malayoside, a cardenolide glycoside extracted from Antiaris toxicaria Lesch, induces apoptosis in human non-small lung cancer cells via MAPK-Nur77 signaling pathway
-
Published:2021-08
Issue:
Volume:190
Page:114622
-
ISSN:0006-2952
-
Container-title:Biochemical Pharmacology
-
language:en
-
Short-container-title:Biochemical Pharmacology
Author:
Hu Qiong-Ying,Zhang Xiao-Kun,Wang Jia-Nan,Chen Hao-Xuan,He Lian-Ping,Tang Jin-Shan,Yao Xin-Sheng,Liu Jie
Funder
Zhejiang Province Public Welfare Technology Application Research Project Fujian Provincial Natural Science Foundation Zhejiang Province Natural Science Foundation National Natural Science Foundation of China
Subject
Pharmacology,Biochemistry
Reference77 articles.
1. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017 2. The biology and management of non-small cell lung cancer;Herbst;Nature,2018 3. The evolving locally-advanced non-small cell lung cancer landscape: Building on past evidence and experience;Mery;Crit. Rev. Oncol. Hematol.,2015 4. Results of PROFILE 1029, a Phase III comparison of first-line crizotinib versus chemotherapy in East Asian Patients with ALK-positive advanced non-small cell lung cancer;Wu;J. Thorac. Oncol.,2018 5. B.J. Solomon, T. Mok, D.W. Kim, Y.L. Wu, K. Nakagawa, T. Mekhail, E. Felip, F. Cappuzzo, J. Paolini, T. Usari, S. Iyer, A. Reisman, K.D. Wilner, J. Tursi, F. Blackhall, M. Boyer, V. Ganju, B. Hughes, N. Pavlakis, B. Solomon, S. Varma, T. Berghmans, J.L. Canon, I. Demedts, A. Janssens, R. Louis, T. Pieters, D. Schallier, V. Surmont, C.M. da Silva, C.G.M. Ferreira, V. Hirsh, A. Joy, F. Laberge, W. Morzycki, R. Wierzbicki, B. Han, X. Liu, S. Qin, Y. Shi, Y. Wang, G. Wu, Y.L. Wu, C. Zhou, J. Ahvonen, F. Barlesi, J. Cadranel, E. Dansin, J. Fayette, J.F. Morere, D. Moro-Sibilot, J.L. Pujol, E. Quoix, G. Zalcman, N. Frickhofen, C.P. Schneider, T. Wehler, T. Mok, P. So, S. Cuffe, A. Bearz, C. Boni, F. Cappuzzo, F. Cognetti, F. De Braud, T. De Pas, D. Galetta, M. Migliorino, D. Rocco, G. Scagliotti, P. Tagliaferri, M. Tiseo, K. Aoe, T. Hida, T. Kato, T. Kozuki, K. Nakagawa, S. Niho, M. Nishio, H. Nokihara, M. Satouchi, T. Seto, T. Takahashi, J.S. Ahn, D.W. Kim, S.W. Kim, G. Berchem, O.A. Rodriguez, B. Biesma, A.M. Dingemans, E. Smit, A. Helland, F. Barata, V. Gorbunova, G. Manikhas, S. Orlov, S. Leong, H.L. Lim, R. Soo, E.H. Tan, A. Nosworthy, M.C. Villena, E. Felip, P.G. Lopez, D.I. Casado, N.M. Banaclocha, S.P. Aix, N.R. Aransay, D.R. Abreu, J.T. Perez, O. Gautschi, M. Pless, A. Zippelius, G.C. Chang, Y.H. Tsai, Y. Shparyk, F. Blackhall, N. Steele, V. Armenio, K. Dragnev, M. Dugan, S. Gadgeel, D. Gerber, S. Graziano, S. Gurubhagavatula, L. Horn, S. Jalal, R. Lauer, R. Mehra, T. Mekhail, H. Mirshahidi, S. Pakkala, J. Polikoff, H. Raftopoulos, M. Saleh, R. Salgia, S. Waqar, P. Investigator, First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer (vol 371, pg 2167, 2014), New Engl. J. Med. 373(16) (2015) 1582-1582.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|